KiraGen Bio
PrivateLast Round
Grant
Dec 31, 2025
Total Funding Raised
$1.45M
Company Overview
KiraGen Bio is a biotechnology company that develops multiplex gene-edited CAR-T cell therapies designed to overcome the immunosuppressive tumor microenvironment in solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
KiraGen Bio Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
KiraGen Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 31, 2025 | ||||
| Accelerator | Apr 23, 2025 | ||||
| Pre Seed | Apr 1, 2025 |
Key People
Founding team and executive leadership
KiraGen Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Lexi Ventures | Pre Seed |
| Harvard Innovation Labs | Pre Seed |
| Gaingels | Pre Seed |
| Yuvaan Tiwari Foundation | Pre Seed |
| ZAKA VC | Pre Seed |
| Conscience VC | Pre Seed |
| 2048 Ventures | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 12, 2025
Featured on The Sheekey Science Show.
- Feb 18, 2025
Advanced to the Boston Regional Finals of the HBS New Venture Competition.
KiraGen Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about KiraGen Bio's valuation, stock price, and market status.